mechanism of action glp-1 agonist Glucagon-like peptide-1 Evolution of GLP‐1 Receptor Agonists
Description
Chen T, Mager DE, Kagan L
The pharmacist can have a key role in educating patients and providers about the importance of regular diabetes follow-up, home glucose monitoring, frequent HbA1c testing, and why multiple medications are needed
Early evidence suggests the drugs might also improve depression and substance abuse disorders
A state of positive energy balance exists in the duration of the energy intake exceeding energy consumption, resulting in the storage of the excess calories in adipose tissue, which first leads to body phenotypic overweight (body mass index, BMI 25-30 kg/m 2 )
By 2030, we expect the market size to exceed $100 billion in the U.S. It is estimated that by then, 1 in 10 Americans will be on a GLP-1 medication
[DOI] [PubMed] [Google Scholar] 92.Wadden T.A., Tronieri J.S., Sugimoto D., Lund M.T., Auerbach P., Jensen C
